Biomedical Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Central 6, 1-1-1 Higashi, Tsukuba, Ibaraki 305-8566, Japan; Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, 5-1-5 Kashiwanoha, Kashiwa, Chiba 277-8562, Japan.
Biomedical Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Central 6, 1-1-1 Higashi, Tsukuba, Ibaraki 305-8566, Japan; Bioproduction Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Central 6, 1-1-1, Higashi, Tsukuba, Ibaraki 305-8566, Japan.
Int J Pharm. 2021 Aug 10;605:120774. doi: 10.1016/j.ijpharm.2021.120774. Epub 2021 Jun 9.
Aggregation of protein therapeutics can lead to immunogenicity and loss of function in vivo. Its effective prevention requires an understanding of the conformational and colloidal stability of protein and the improvement of both. Granulocyte colony-stimulating factor (G-CSF), which is one of the most widely used protein therapeutics, was previously shown to be conformationally stabilized by connecting its N- and C-termini with amide bonds (backbone circularization). In this study, we investigated whether circularization affects the colloidal stability of proteins. Colloidal stability was indirectly assessed by analyzing the aggregation behavior of G-CSF variants using analytical ultracentrifugation (AUC) and small-angle X-ray scattering (SAXS). Consequently, we found that the unfolded structure of circularized G-CSF was more compact than non-circularized G-CSF, and that backbone circularization improved its aggregation resistance against chemical denaturation by guanidine hydrochloride (GdnHCl). The improved aggregation resistance suggests that the expansion tolerance of circularized G-CSF in the unfolded state increased its colloidal stability. Thus, backbone circularization is an excellent method for enhancing the colloidal and the conformational stability of protein with minimal sequence changes. It is therefore expected to be effective in extending the storage stability of protein therapeutics, enhancing their biological stability.
蛋白质治疗剂的聚集会导致体内的免疫原性和功能丧失。其有效预防需要了解蛋白质的构象和胶体稳定性,并改善这两者。粒细胞集落刺激因子(G-CSF)是应用最广泛的蛋白质治疗剂之一,先前的研究表明,通过酰胺键(骨干环化)连接其 N 端和 C 端可以使 G-CSF 构象稳定。在这项研究中,我们研究了环化是否会影响蛋白质的胶体稳定性。通过使用分析超速离心(AUC)和小角 X 射线散射(SAXS)分析 G-CSF 变体的聚集行为,间接评估胶体稳定性。结果发现,环化的 G-CSF 的无规卷曲结构比非环化的 G-CSF 更紧凑,并且骨干环化提高了 G-CSF 对盐酸胍(GdnHCl)化学变性的抗聚集能力。提高的抗聚集能力表明,环化的 G-CSF 在展开状态下的扩展容忍度增加了其胶体稳定性。因此,骨干环化是一种增强蛋白质胶体和构象稳定性的极好方法,只需最小的序列变化。因此,预计它将有效延长蛋白质治疗剂的储存稳定性,增强其生物学稳定性。